Tavaborole Solution
Product Images NDC 69097-686

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tavaborole (NDC 69097-686). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 01)

FDA Label Image

4ml (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 02)

This text appears to be a mixture of different information related to a topical solution called Tavaborole. It provides some instructions on how to use the solution, including the temperature at which it should be stored and the need to keep the bottle closed. It also indicates the manufacturer and the batch information for the overprinting. However, it is not clear what the term "Unwinding Direction" means in this context.*

FDA Label Image

4ml (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 03)

This is a description of a topical solution called Tavaborole. The solution is intended for topical use only, and not for oral, ophthalmic or intravaginal use. The package contains 4 mL of solution and has a warning to keep it out of reach of children and to avoid contact with eyes. The solution contains 43.5 mg of tavaborole, alcohol USP (74.81% v/v), propylene glycol USF, and edetate calcium disodium USP. The dosing information can be found in the package insert, and the solution should only be used as prescribed by a physician. The package also has caution to keep the bottle tightly closed and away from heat and flames due to its flammable nature. The solution is manufactured by Encube Ethicals Pvt. Ltd in India and is distributed by Cipla USA, Inc.*

FDA Label Image

10ml (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 04)

This is a medication called Tavaborole, provided in a Topical Solution meant for external use only. It should be kept in a tightly closed bottle and stored in a temperature range of 15°C-30°C. It is not meant for internal use, including oral, ophthalmic, or intravaginal use. The manufacturer is noted as EnCube Ethicals P. Ltd. and manufactured by Ponca, Goa-403 404, India, and Cipla USA, Inc., Suito 300, Warren, NJ 07050. This label also includes an area for batch over printing.*

FDA Label Image

10ml (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 05)

This is a description of a topical solution called Tavaborole, manufactured by Cipla, intended for topical use only. It contains 43.5 mg of tavaborole per mL of solution, mixed with alcohol USP 74.81% v/v, propylene glycol USP, and edetate calcium disodium USP. The product should only be used as directed and comes with a dropper for application. It is not intended for oral, ophthalmic, or intravaginal use and should be kept away from children and out of the eyes. The device includes dry natural rubber and is flammable. The manufacturing facility is located in Ponda, Goa, India, and the product is made for Cipla USA, Inc.*

FDA Label Image

Image (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 68 2)

FDA Label Image

Image (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 68 3)

FDA Label Image

Image (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 68 4)

FDA Label Image

Image (Ac0a7dcc 4cd8 412b 8238 Bbc23aa5cdc6 68 5)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.